[LGND] YoY Annual Result on 31-Dec-2008 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
16-Mar-2009
Financial Year
2008
Quarter
31-Dec-2008 [#FY]
Profit Trend
YoY- -134.83%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Revenue 30,037 23,538 38,940 27,315 12,894 140,960 176,608 -25.55%
PBT -2,930 -15,403 -9,872 -97,515 -53,456 -174,273 36,340 -
Tax -13,103 -2,617 -7,924 -55 -18,697 -38,414 59 -
NP 10,176 -12,515 -1,948 -98,114 281,688 -31,743 -36,399 -
Tax Rate - - - - - - -0.16% -
Total Cost 19,861 36,053 40,888 125,429 -268,794 172,703 213,007 -32.64%
Ratio Analysis
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
NP Margin 33.88 -53.17 -5.00 -359.19 2,184.64 -22.52 -20.61 -
Per Share
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
EPS 0.52 -0.64 -0.10 -6.16 17.22 -2.36 -2.95 -
EPS Diluted 0.52 -0.64 -0.10 -6.16 17.22 -2.36 -2.95 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.